Directory Last Updated: 02 May 2024
Return to Directory Key Opinion Leaders Special Interests word selected: DEVELOPMENT in town: LONDON
Names, CVs (as available), locations and contact details of Investigators are available to Subscribers.
To subscribe, please contact Emma Taylor at emma@specialistinfo.com or 01423 727 724 for details on subscription costs.
PhraseConsultantTownSpecial Interests
Child development*Consultant(s)**Towns*Child development, neurodisability, looked-after children, assessment of autism and ADHD
development neuropsychiatry*Consultant(s)**Towns*Early onset psychoses, development neuropsychiatry, paediatric psychopharmacology, inpatient treatment in children
Development of cancer vaccines*Consultant(s)**Towns*Development of cancer vaccines, adoptive T-cell therapy of cancer, gene therapy of cancer
development of Neurotrauma Services*Consultant(s)**Towns*Neurotrauma, head injuries, spine injuries, complex cranial neurosurgery, development of Neurotrauma Services, skull base surgery, neuroendoscopic procedures, management of complex CSF - cerebrospinal fluid disorders
development of new treatments for psychosis*Consultant(s)**Towns*Mechanisms underlying psychotic symptoms and psychosis, development of new treatments for psychosis
drug development*Consultant(s)**Towns*Medical oncology, drug development, ovarian cancer, endometrial cancer, cervical cancer, early phase clinical trials
drug development - childhood cancer*Consultant(s)**Towns*Paediatric neuro-oncology, drug development - childhood cancer, the biology of childhood malignant glioma, drug development
gastrointestinal immunity and infections and vaccine development*Consultant(s)**Towns*IBD - inflammatory bowel disease, Crohn's disease, ulcerative colitis, gastrointestinal immunity and infections and vaccine development, nutrition and irritable bowel syndrome - IBS, dyspepsia and reflux disease, feeding tube placement and nutrition, endoscopic ultrasound and laser therapy
growth and development*Consultant(s)**Towns*Paediatric endocrinology, neuroendocrine and late effects of childhood malignancy, adolescence to 21yrs, growth and development, reproductive maturity, Turner's syndrome, congenital adrenal hyperplasia, short stature, paediatric endocrine oncology, pituitary tumours in childhood
imaging in drug development*Consultant(s)**Towns*Diagnostic radiology, MRI, CT, oncology, functional MRI, imaging in drug development, prostate MRI
International development*Consultant(s)**Towns*International development, adult psychiatry, transcultural psychiatry
management and service development*Consultant(s)**Towns*Leadership, management and service development, enhanced care
phase 1 drug development*Consultant(s)**Towns*Medical oncology, lung cancer, head and neck cancer, phase 1 drug development
pituitary development*Consultant(s)**Towns*Paediatric endocrinology, pituitary development, septo-optic dysplasia
service development and clinical leadership*Consultant(s)**Towns*Palliative medicine, pain management and complex system control, advance care planning, service development and clinical leadership, postgraduate medical education, patient safety and risk management
Spacer

Third Party Advertisement

Adverts by Google